This transcript has been edited for clarity. Anne Cross, MD: Hello. I am Dr Anne Cross and welcome to Medscape's InDiscussion series on multiple sclerosis (MS). Today we'll be discussing cognitive ...
Mayo Clinic and Acorda Therapeutics, Inc. (Nasdaq: ) today announced that the first patient has been enrolled in the first clinical trial of rHIgM22, a remyelinating antibody being studied for the ...
It's a disease hidden in plain sight. Multiple Sclerosis (MS) impacts about 1 in every 400 people, according to the Multiple Sclerosis Clinic at Riverside Regional Medical Center. That means about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback